Maksim Labkouski Intercept Prescription drugs (NASDAQ:ICPT) has been downgraded to carry by Canaccord Genuity within the wake of stories that the biotech group has agreed to be acquired by… Read More

Boston, Massachusetts--(Newsfile Corp. - May 18, 2023) - Block & Leviton is investigating Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) for potential securities law violations. Investor… Read More

The most recent 13F filing that Intercept Pharmaceuticals, Inc. made with the Securities and Exchange Commission revealed that SG Americas Securities LLC increased its holdings in the compan… Read More

SAN FRANCISCO: Today, Komodo Health announced a collaboration with Intercept Pharmaceuticals (Nasdaq: ICPT), powering clinical research and new real-world evidence (RWE) with Komodo’… Read More

New York, New York--(Newsfile Corp. - December 16, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Intercept Pharmaceuticals, Inc. ("Intercept" or the "Company") (NAS… Read More

Philadelphia, Pennsylvania--(Newsfile Corp. - October 23, 2021) - Kaskela Law LLC announces that it is investigating Intercept Pharmaceuticals, Inc. ("Intercept" or the "Company") (NASDAQ:… Read More

Short-sellers are back for revenge after getting crushed during 2020 and the better part of last year. New research from Axios shows consumer discretionary are the most shorted stocks i… Read More

New York, New York--(Newsfile Corp. - December 26, 2020) - Pomerantz LLP announces that a class action lawsuit has been filed against Intercept Pharmaceuticals, Inc. ("Intercept" or the "Co… Read More

Just yesterday Intercept Pharma (NASDAQ:ICPT) traded -24.89% lower at $73.70. The company’s 50-day moving average is $106.75 and its 200-day moving average is $115.74. With the last… Read More

Latest stock market news for June 29, 2020. The US stock market closed higher ignoring the fears about the second wave of coronavirus outbreak. Dow Jones gained more than 580 points, S&P… Read More

Finally, Needham & Company LLC reaffirmed a hold rating on shares of Intercept Pharmaceuticals in a research note on Wednesday, October 31st. In related news, EVP Christian Weyer sold… Read More

Bio-Path Holdings, Inc. (NASDAQ: BPTH) experienced a high price of $8.84 with a low value of $2.65 at the end of the last trading session, which followed after a gain of 196.92% and settled… Read More